Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2026-01-19 @ 6:33 PM
Study NCT ID:
NCT03182257
Status:
TERMINATED
Last Update Posted:
2019-09-13
First Post:
2017-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors
Sponsor:
Ono Pharmaceutical Co. Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumor | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | TRK | View |
| None | TRKA | View |
| None | TRKB | View |
| None | TRKC | View |
| None | NTRK1 | View |
| None | NTRK2 | View |
| None | NTRK3 | View |
| None | NTRK fusion positive | View |
| None | NTRK1 fusion | View |
| None | NTRK2 fusion | View |
| None | NTRK3 fusion | View |
| None | NTRK1 gene rearrangement | View |
| None | NTRK2 gene rearrangement | View |
| None | NTRK3 gene fusion | View |
| None | ETV6-NTRK3 | View |
| None | fusion | View |
| None | tumors | View |
| None | solid tumors | View |
| None | CNS tumors | View |
| None | central nervous system tumors | View |
| None | TRK fusion | View |
| None | ETV6 | View |
| None | ETV6 fusion | View |
| None | solid CNS tumor | View |
| None | advanced CNS tumor | View |
| None | primary CNS tumor | View |